AHA, ACC release standard definition set for diagnosis and treatment of Covid

American College of Cardiology

The American College of Cardiology and the American Heart Association have released a comprehensive set of data standards to help standardize definitions and set the framework to capture and better understand how COVID-19 impacts cardiovascular health.

Individuals with cardiovascular risk factors or a preexisting cardiovascular condition are at greater risk for severe infection from COVID-19, and there is increased importance of understanding the acute and longitudinal impact of COVID-19 on cardiovascular health. Unfortunately, there has not been clarity or consensus on definitions of cardiovascular conditions related to COVID-19. Broad agreement on common vocabulary and definitions is needed to pool or compare data from electronic health

records (EHRs), clinical registries, administrative datasets and other databases, and to assess whether these data are applicable to clinical practice and research endeavors.

This document is intended for use by researchers, registry developers and clinicians, and is proposed as a framework for ICD-10 code development of COVID–19–related cardiovascular conditions. The standards are also of great importance to patients, clinicians, investigators, scientists, administrators, public health officials, policymakers and payers.

The new data standard provides health care professionals a framework with which to lead conversations with their patients by standardizing terminology and attributes for the diagnosis of COVID-19; cardiovascular and noncardiovascular complications; symptoms and signs; diagnostic procedures; pharmacological therapy; preventive, therapeutic and supportive procedures; and end-of-life care management.

The 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19 will publish online in the Journal of the American College of Cardiology and Circulation: Cardiovascular Quality and Outcomes on Thursday, June 23, 2022 at 2:00 p.m. ET. It was endorsed by the Heart Failure Society of America and the Society for Cardiac Angiography and Interventions.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.